MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 11 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,293,000 | +7.9% | 4,239,000 | 0.0% | 0.09% | -2.2% |
| Q2 2016 | $4,907,000 | -24.8% | 4,239,000 | 0.0% | 0.09% | -24.4% |
| Q1 2016 | $6,525,000 | +60.1% | 4,239,000 | +54.4% | 0.12% | +66.2% |
| Q4 2015 | $4,076,000 | -17.9% | 2,745,000 | -12.0% | 0.07% | -26.0% |
| Q3 2015 | $4,965,000 | -27.9% | 3,120,000 | -4.7% | 0.10% | -24.2% |
| Q2 2015 | $6,886,000 | -5.8% | 3,275,000 | -10.2% | 0.13% | -4.3% |
| Q1 2015 | $7,308,000 | +6.4% | 3,645,000 | 0.0% | 0.14% | +3.0% |
| Q4 2014 | $6,869,000 | +21.2% | 3,645,000 | 0.0% | 0.13% | +12.6% |
| Q3 2014 | $5,668,000 | +20.1% | 3,645,000 | +4.3% | 0.12% | +19.0% |
| Q2 2014 | $4,718,000 | +53.5% | 3,495,000 | +15.5% | 0.10% | +42.9% |
| Q1 2014 | $3,074,000 | +45.8% | 3,025,000 | +49.4% | 0.07% | +40.0% |
| Q4 2013 | $2,109,000 | +102.4% | 2,025,000 | +76.1% | 0.05% | +78.6% |
| Q3 2013 | $1,042,000 | – | 1,150,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 16,490,000 | $25,947,000 | 12.49% |
| SILVERBACK ASSET MANAGEMENT LLC | 14,500,000 | $22,711,000 | 2.37% |
| TANG CAPITAL MANAGEMENT LLC | 3,500,000 | $5,259,000 | 1.94% |
| ARISTEIA CAPITAL, L.L.C. | 11,932,000 | $18,727,000 | 0.95% |
| WOLVERINE ASSET MANAGEMENT LLC | 12,600,000 | $19,576,000 | 0.46% |
| Polar Capital LLP | 3,120,000 | $4,965,000 | 0.10% |
| Tekla Capital Management LLC | 1,485,000 | $2,336,000 | 0.08% |
| MIZUHO SECURITIES USA LLC | 194,000 | $305,000 | 0.08% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,410,000 | $2,206,000 | 0.06% |
| LAZARD ASSET MANAGEMENT LLC | 11,010,000 | $17,375,000 | 0.04% |